Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: KERICURE INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-09-22 to 2026-01-21
Current total value of award: $1299857.19
Description: DHA SEQUENTIAL PHASE II SBIR DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE